Research Article
Efficacy of Acupuncture and Moxibustion as a Subsequent Treatment after Second-Line Chemotherapy in Advanced Gastric Cancer
Table 2
Baseline characteristics of treatment and control groups.
| | Parameter | Treatment group | Control group | | | N = 81 (%) | N = 54 (%) | |
| | Age, y | | | 0.879 | | <60 | 56 (69.1) | 38 (70.4) | | | ≥60 | 25 (30.9) | 16 (29.6) | | | Sex | | | 0.559 | | Male | 50 (61.7) | 36 (66.7) | | | Female | 31 (38.3) | 18 (33.3) | | | Primary tumor location | | | 0.793 | | Cardia and fundus | 11 (13.6) | 5 (9.3) | | | Antrum | 31 (38.3) | 22 (40.7) | | | Corpus | 36 (44.4) | 26 (48.1) | | | Whole | 3 (3.7) | 1 (1.9) | | | Primary tumor size | | | 0.603 | | <6 cm | 63 (77.8) | 44 (81.5) | | | ≥6 cm | 18 (22.2) | 10 (18.5) | | | ECOG performance status | | | 0.841 | | 0 | 32 (39.5) | 21 (38.9) | | | 1 | 25 (30.9) | 19 (35.2) | | | 2 | 24 (29.6) | 14 (25.9) | | | Differentiation | | | 0.675 | | Well | 8 (9.9) | 5 (9.3) | | | Moderate | 45 (55.6) | 34 (63.0) | | | Poor | 28 (34.6) | 15 (27.8) | | | Metastatic sites per patient | | | 0.888 | | 1-2 | 38 (46.9) | 26 (48.1) | | | >2 | 43 (53.1) | 28 (51.9) | | | Type of gastric cancer | | | 0.485 | | Intestinal | 42 (51.9) | 30 (55.6) | | | Diffuse | 17 (21.0) | 14 (21.9) | | | Mixed | 22 (27.2) | 10 (18.5) | | | Extent of disease at study entry | | | 0.818 | | Locally advanced | 8 (9.9) | 6 (11.1) | | | Metastatic | 73 (90.1) | 48 (88.9) | |
|
|
